GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing treatments for glaucoma, corneal disorders, and retinal diseases. The company's flagship product line includes micro-invasive glaucoma surgery (MIGS) devices designed to reduce intraocular pressure in glaucoma patients. Glaukos also develops pharmaceutical therapies and innovative surgical devices for various eye conditions. The company serves ophthalmologists and eye care professionals worldwide, competing in the growing market for minimally invasive eye disease treatments.